Clinical trial

Can Advair and Flovent Reduce Systemic Inflammation Related to Chronic Obstructive Pulmonary Disease (COPD)? A Multi-Center Randomized Controlled Trial

NCT00120978

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2004-12-01

PhasePHASE4

Study timeline

Study start (unknown)2004-12-01Date precision: month

Registry last updated2006-05-09

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Chronic Obstructive Pulmonary Diseaseunresolved

Interventions

AdvairDRUG · verified · RxNorm: Advair

FloventDRUG · verified · RxNorm: Flovent

Sponsors & collaborators

University of British Columbialead sponsor

GlaxoSmithKlinecollaborator

Mapped research locations

EdmontonAlberta, Canada3 VancouverBritish Columbia, Canada2 CalgaryAlberta, Canada1 SaskatoonSaskatchewan, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00120978 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.